Cannabinoids have established themselves as therapeutic options in the treatment of pain in recent years. Nevertheless, patients can experience problems when using them, particularly with regard to tolerance. A new aqueous nanodispersion appears to be able to eliminate these problems.
Autoren
- Jens Dehn
Publikation
- InFo RHEUMATOLOGIE
Related Topics
You May Also Like
- Case report: alveolar sarcoidosis
Acute hypoxemic respiratory failure as initial manifestation
- "Swiss Health Care Atlas"
Supply situation in Switzerland: Update
- Lung cancer
Multidisciplinary teams in oncology
- Adrenogenital syndrome
Clinical care from birth to adulthood
- Psoriasis: System therapies in everyday practice
Current real-world data at a glance
- Omega-3 fatty acids for obesity and type 2 diabetes
More fish oil for better lipid and HbA1c levels
- MASLD often goes unnoticed and is underestimated
Think tank for improving the supply situation
- DGPPN Congress